論文

査読有り 責任著者 国際誌
2020年5月1日

Decreased ADAM17 expression in the lungs of α-Klotho reduced mouse.

Journal of biochemistry
  • Keiko Akasaka-Manya
  • ,
  • Hiroshi Manya
  • ,
  • Satomi Nadanaka
  • ,
  • Hiroshi Kitagawa
  • ,
  • Yoshitaka Kondo
  • ,
  • Akihito Ishigami
  • ,
  • Tamao Endo

167
5
開始ページ
483
終了ページ
493
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1093/jb/mvz113

The deficiency of α-Klotho in mice causes phenotypes resembling human age-associated disorders at 3-4 weeks after birth and shows short lifespans of ∼2 months. One of the crucial symptoms is pulmonary emphysema, although α-Klotho is not expressed in the lungs. α-Klotho secreted from the kidneys is probably involved in the pathology of emphysema because kidney-specific knockout mice exhibit emphysematous structural changes. We examined whether any glycan changes in α-Klotho mouse lungs were observed, because α-Klotho is reported to have glycosidase activity. Here, we found the accumulation of heparan sulphate in the microsomal fraction of α-Klotho mouse lungs. Meanwhile, a disintegrin and metalloproteinase 17 (ADAM17) expression was decreased in α-Klotho mice. From these results, it is thought that the increase in heparan sulphate is due to insufficient cleavage of the core protein by ADAM17. Additionally, a reduction in α-Klotho and a decline of ADAM17 were also observed both in normal aged mice and in senescence marker protein-30 (SMP30) knockout mice, a mouse model of premature ageing. Thus, the decrease in ADAM17 is caused by the reduction in α-Klotho. These may be involved in the deterioration of lung function during ageing and may be associated with the pathology of pulmonary emphysema.

リンク情報
DOI
https://doi.org/10.1093/jb/mvz113
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31951006
ID情報
  • DOI : 10.1093/jb/mvz113
  • PubMed ID : 31951006

エクスポート
BibTeX RIS